Literature DB >> 7437256

Propranolol LA and ambulatory blood pressure.

S Mann, M W Craig, V Balasubramanian, E B Raftery.   

Abstract

1 The technique of continuous recording of intra-arterial blood pressure in ambulant hypertensives has been used to investigate the effects of a long-acting formulation of propranolol (propranolol LA). 2 Seven subjects with untreated essential hypertension were studied before and 2 months after commencing treatment with propranolol LA once daily in the morning, results showing that smooth control of blood pressure and heart rate occurred throughout 24 h. 3 Bicycle ergometry tests performed by these subjects during both studies showed significant blood pressure reduction by propranolol LA during the mild and moderate grades of dynamic exercise. 4 In a parallel study where six treated hypertensives were monitored before and after substitution of standard propranolol by the 'LA' form, close correspondence of blood pressure throughout the 24 h occurred with each regimen.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437256      PMCID: PMC1430160          DOI: 10.1111/j.1365-2125.1980.tb01786.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Beta-blockers: once or three times a day?

Authors:  T Reybrouck; A Amery; R Fagard; P Jousten; P Lijnen; E Meulepas
Journal:  Br Med J       Date:  1978-05-27

2.  Assessment of the antihypertensive effect of atenolol with 24 h ambulatory monitoring of blood pressure.

Authors:  J S Floras; P Fox; M O Hassan; J V Jones; P Sleight; K L Turner
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

3.  The effects of metoprolol on ambulatory blood pressure.

Authors:  S Mann; M W Craig; D G Altman; D I Melville; E B Raftery
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

4.  New system for recording ambulatory blood pressure in man.

Authors:  M W Millar-Craig; D Hawes; J Whittington
Journal:  Med Biol Eng Comput       Date:  1978-11       Impact factor: 2.602

5.  Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.

Authors:  R D Watson; T J Stallard; W A Littler
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

6.  Pharmacokinetic and pharmacodynamic studies with long-acting propranolol.

Authors:  J McAinsh; N S Baber; R Smith; J Young
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

7.  Effect of once-daily atenolol on ambulatory blood pressure.

Authors:  M W Craig; D Kenny; S Mann; V Balasubramanian; E B Raftery
Journal:  Br Med J       Date:  1979-01-27

8.  Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol.

Authors:  W J Leahey; J D Neill; M P Varma; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

9.  Blood pressure circadian rhythm in essential hypertension.

Authors:  M W Millar Craig; S Mann; V Balasubramanian; E B Raftery
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

10.  Circadian variation of blood-pressure.

Authors:  M W Millar-Craig; C N Bishop; E B Raftery
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

View more
  12 in total

1.  Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects.

Authors:  B Langner; B Lemmer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Control of blood pressure and reduction of echocardiographically assessed left ventricular mass with one-daily timolol.

Authors:  D B Rowlands; D R Glover; T J Stallard; W A Littler
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

3.  Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring.

Authors:  M H Rustin; E N Coomes
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

4.  The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.

Authors:  M W Millar-Craig; S Mann; V Bala Subramanian; D G Altman; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.

Authors:  V M Oh; B L Chia; E A Taylor
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

6.  Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.

Authors:  A Nissinen; A Koistinen; J Tuomilehto; S Sundberg; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 7.  Pharmacokinetics of long acting propranolol. Implications for therapeutic use.

Authors:  G S Nace; A J Wood
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

8.  Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.

Authors:  M M Kubik; J H Coote
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Long acting beta-blockers in the twenty fourth hour.

Authors:  G I Hackett; P Harrison; S Kershaw
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man.

Authors:  R Koopmans; B Oosterhuis; J M Karemaker; J Wemer; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.